Glaukos pioneered Micro-Invasive Glaucoma Surgery (MIGS) to revolutionise the traditional glaucoma treatment and management paradigm.
In 2016, Glaukos Australia launched the iStent inject. Delivering two preloaded trabecular micro-bypass stents with a single entry, iStent inject optimises the benefits of MIGS; it is designed to improve aqueous outflow through the natural physiological outflow pathway. iStent inject is intended to reduce intraocular pressure in adult patients diagnosed with mild to moderate primary open angle glaucoma currently treated with ocular hypotensive medication. It can be implanted with or without cataract surgery.